Clinical Trial Update: The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TLR4 inhibition in obese and type 2 diabetic subjects completed; results posted after termination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Insulin Sensitivity | Phase 2 | Status: TERMINATED | Results posted: 2020-03-04